TXNRD1 and gastric cancer: Recent studies have revealed that targeting TXNRD1 with small molecules is a viable approach to achieving therapeutic activity and selectivity, indicating the anti-cancer potential of inhibiting TXNRD1 in gastric cancer [25,26].